Evidence map›Paper›PMID 24797663›Full record

Trial reportPloS one2014

Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction.

Irene Fernández-Ruiz, Francisco Arnalich, Carolina Cubillos-Zapata, Enrique Hernández-Jiménez, Raúl Moreno-González, Víctor Toledano, María Fernández-Velasco, Maria T Vallejo-Cremades, Laura Esteban-Burgos, Rebeca Pérez de Diego and 7 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Traumatic inflammatory response: pathophysiological role and clinical value of cytokines.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Irene Fernández-RuizTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
Francisco ArnalichInternal Medicine Service, Hospital La Paz, Madrid, Spain.
Carolina Cubillos-ZapataTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
Enrique Hernández-JiménezTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
Raúl Moreno-GonzálezCardiology Service, Hospital La Paz, Madrid, Spain.
Víctor ToledanoTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
María Fernández-VelascoTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Institute of Biomedical Research, Alberto Sols, Madrid, Spain.
Maria T Vallejo-CremadesTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain.
Laura Esteban-BurgosTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
Rebeca Pérez de DiegoInnate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain; Laboratory of Immunogenetics of Diseases, IdiPAZ, La Paz Hospital, Madrid, Spain.
Miguel A Llamas-MatiasEMPIREO Laboratory, Madrid, Spain.
Elena García-ArumiDepartment of Mitochondrial and Neuromuscular Pathology, Vall d'Hebron Research Institute, Barcelona, Spain.
Ramón MartíDepartment of Mitochondrial and Neuromuscular Pathology, Vall d'Hebron Research Institute, Barcelona, Spain.
Lisardo BoscáInnate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain; Institute of Biomedical Research, Alberto Sols, Madrid, Spain.
Antoni L AndreuDepartment of Mitochondrial and Neuromuscular Pathology, Vall d'Hebron Research Institute, Barcelona, Spain.
José Luis López-SendónCardiology Service, Hospital La Paz, Madrid, Spain.
Eduardo López-CollazoTumor Immunology Lab, IdiPAZ, Hospital La Paz, Madrid, Spain; Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
Hospital La Paz Institute for Health Research · ESHospital Universitario La Paz · ESVall d'Hebron Institut de Recerca · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocyte exposure to mitochondrial Danger Associated Molecular Patterns (DAMPs), including mitochondrial DNA (mtDNA), induces a transient state in which these cells are refractory to further endotoxin stimulation. In this context, IRAK-M up-regulation and impaired p65 activity were observed. This phenomenon, termed endotoxin tolerance (ET), is characterized by decreased production of cytokines in response to the pro-inflammatory stimulus. We also show that monocytes isolated from patients with myocardial infarction (MI) exhibited high levels of circulating mtDNA, which correlated with ET status. Moreover, a significant incidence of infection was observed in those patients with a strong tolerant phenotype. The present data extend our current understanding of the implications of endotoxin tolerance. Furthermore, our data suggest that the levels of mitochondrial antigens in plasma, such as plasma mtDNA, should be useful as a marker of increased risk of susceptibility to nosocomial infections in MI and in other pathologies involving tissue damage.

Indexed as

Up-RegulationAgedCross InfectionCytokinesDNA, MitochondrialEndotoxinsFemaleHumansInterleukin-1 Receptor-Associated KinasesMaleMiddle AgedMonocytesMyocardial InfarctionRisk FactorsCytokinesDNA, MitochondrialEndotoxinsInterleukin-1 Receptor-Associated KinasesIRAK3 protein, human

Identifiers

PMID24797663
PMCPMC4010397
OpenAlexW2068050275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.